| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Omeprazole | Desmethyl Omeprazole | VL112014 | View CAS 301669-82-9 |
| Omeprazole | Esomeprazole Des Methyl Sulfide | VL112013 | View |
| Omeprazole | Esomeprazole EP Impurity F | VL112015 | View CAS 161796-77-6 |
| Omeprazole | Esomeprazole Hydrolysis Impurity | VL112020 | View |
| Omeprazole | Omeprazole Chloro Impurity | VL112009 | View |
| Omeprazole | Omeprazole EP Impurity A | VL112002 | View CAS 37052-78-1 |
| Omeprazole | Omeprazole EP Impurity B | VL112003 | View CAS 110374-16-8 |
| Omeprazole | Omeprazole EP Impurity C | VL112004 | View CAS 73590-85-9 |
| Omeprazole | Omeprazole EP Impurity D | VL112001 | View CAS 88546-55-8 |
| Omeprazole | Omeprazole EP Impurity E | VL112005 | View CAS 176219-04-8 |
| Omeprazole | Omeprazole EP Impurity F | VE0010595 | View CAS 125656-82-8 |
| Omeprazole | Omeprazole EP Impurity G | VE0010150 | View CAS 125656-83-9 |
| Omeprazole | Omeprazole EP Impurity H | VL112007 | View CAS 863029-89-4 |
| Omeprazole | Omeprazole EP Impurity I | VL112008 | View CAS 158812-85-2 |
| Omeprazole | Omeprazole EP Impurity XI | VL112010 | View CAS 86604-75-3 |
| Omeprazole | Omeprazole Hydroxymethyl Impurity | VL3850080 | View CAS 96300-88-8 |
| Omeprazole | Omeprazole Hydroxymethyl Impurity (Free Base) | VE0010069 | View CAS 86604-78-6 |
| Omeprazole | Omeprazole Impurity 48 | VE0012051 | View CAS 106135-28-8 |
| Omeprazole | Omeprazole N-Methyl Impurity | VL112011 | View |
| Omeprazole | Omeprazole Pyridone Acid Impurity | VE007889 | View CAS 1227380-90-6 |
| Omeprazole | Omeprazole Pyridone Acid Sodium salt | VL112019 | View |
| Omeprazole | Omeprazole Related Compound F and G Mixture | VL112006 | View |
| Omeprazole | 4-Chloro-2-(chloromethyl)-3, 5-dimethylpyridine | VE008909 | View CAS 142885-96-9 |
| Omeprazole | 6-Methoxy-1-((4-methoxy-3, 5-dimethylpyridin-2-yl)methyl)-2-(((4-methoxy-3, 5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole | VE0011195 | View CAS 1346599-85-6 |
| Omeprazole | (R)-Omeprazole | VE006621 | View CAS 119141-89-8 |
Omeprazole Related Compound
Oxaliplatin is also used with other drugs to prevent the spread of colon cancer in persons who have had surgery to remove the tumor.
References
- Cleveland Clinic Cancer. “Oxaliplatin – Chemotherapy Drugs – Chemocare.” Chemocare.com, 2023, chemocare.com/chemotherapy/drug-info/oxaliplatin.aspx#:~:text=Oxaliplatin%20is%20classified%20as%20an%20alkylating%20agent.,cell%2Dcycle%20non%2Dspecific. Accessed 10 Apr. 2023.
- Shin, J. M., & Sachs, G. (2008). Pharmacology of proton pump inhibitors. Current gastroenterology reports, 10(6), 528-534. https://doi.org/10.1007/s11894-008-0107-7
- “Oxaliplatin.” Macmillan.org.uk, 2023, www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/oxaliplatin#:~:text=Oxaliplatin%20is%20a%20chemotherapy%20drug,and%20cancer%20of%20the%20oesophagus. Accessed 10 Apr. 2023.
FAQ
What is the classification of oxaliplatin?
Oxaliplatin is a kind of alkylating agent. Alkylating agents are particularly active during the cell’s resting phase. These medications are not cell-cycle specific.
What is the mechanism of action of omeprazole?
Omeprazole is a proton pump inhibitor (PPI) that irreversibly inhibits the hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) enzyme system of the gastric parietal cell, which reduces acid secretion in the stomach
What type of cancer is oxaliplatin used for?
Oxaliplatin is a chemotherapeutic medication that is used to treat bowel cancer, stomach cancer, pancreatic cancer, and esophageal cancer.
